Using the mutant-specific primer pair, we detected the BRAF V595E mutation in one prostatic carcinoma sample (PC2) and four urothelial carcinoma tissues (UC1, UC4, UC5, and UC6). This evidence concerns the gene BRAF and urothelial carcinoma.